Expert Ratings for EyePoint Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 5 analysts have published their opinion on EyePoint Pharmaceuticals (NASDAQ:EYPT) stock. The majority of the ratings are bullish with an average price target of $26.8, a 0.74% decrease from the previous average price target of $27.00.
November 02, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts are mostly bullish on EyePoint Pharmaceuticals (NASDAQ:EYPT) with an average price target of $26.8, a slight decrease from the previous target.
The majority of the analysts are bullish on EYPT, which indicates a positive sentiment towards the stock. The slight decrease in the average price target could be due to a variety of factors, including changes in market conditions or company fundamentals. However, the overall bullish sentiment suggests that the stock is expected to perform well in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100